Vilya

Vilya is a biotechnology company. The company's proprietary platform, powered by advanced machine learning, leverages unexplored chemical space to design molecular structures from scratch. These molecules are intermediate in size between small molecules and antibodies, possessing key drug-like properties, including the ability to move through biological membranes and disrupt protein-protein interactions, while maintaining high selectivity for their protein targets. These novel artificial molecules, with tailored biological properties, can be applied across a wide range of indications to address previously difficult-to-drug therapeutic targets.